Novavax (NVAX)
(Delayed Data from NSDQ)
$4.09 USD
+0.14 (3.54%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $4.07 -0.02 (-0.49%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth B Momentum D VGM
Earnings News For NVAX
-
Novavax (NVAX) Down 3.2% Since Last Earnings Report: Can It Rebound?
-
Novavax (NVAX) Q4 Earnings & Sales Miss Estimates, Stock Tanks
-
Novavax: Q4 Earnings Snapshot
-
Novavax (NVAX) Reports Q4 Loss, Lags Revenue Estimates
-
Novavax Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
-
Novavax (NVAX) Q4 Earnings Preview: What's in the Cards?
-
Novavax (NVAX) Beats on Q3 Earnings & Sales, Cuts Sales View
-
Novavax: Q3 Earnings Snapshot
-
Novavax Reports Third Quarter 2023 Financial Results and Operational Highlights
-
Novavax (NVAX) Up 36.8% Since Last Earnings Report: Can It Continue?
-
Novavax (NVAX) Q2 Earnings Beat, Stock Down 4% on '23 Sales Cut
-
Novavax (NVAX) Q2 Earnings and Revenues Top Estimates
-
Novavax: Q2 Earnings Snapshot
-
Novavax Reports Second Quarter 2023 Financial Results and Operational Highlights
-
Why Is Novavax (NVAX) Down 14.7% Since Last Earnings Report?
-
Novavax (NVAX) Q1 Earnings Lag, Stock Up 28% on Upbeat '23 View
-
Novavax (NVAX) Reports Q1 Loss, Lags Revenue Estimates
-
Novavax: Q1 Earnings Snapshot
-
Novavax Reports First Quarter 2023 Financial Results and Operational Highlights
-
Novavax (NVAX) to Report Q1 Earnings: What's in the Cards?
-
Novavax (NVAX) Down 2.9% Since Last Earnings Report: Can It Rebound?
-
Novavax (NVAX) Q4 Earnings & Revenues Miss Estimates, Stock Down
-
Novavax (NVAX) Reports Q4 Loss, Misses Revenue Estimates
-
Novavax: Q4 Earnings Snapshot
-
Novavax Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights